GET THE APP

Docking, dynamic simulation and quantum mechanics studies of pyrazinamide derivatives as novel inhibitors of Acetylcholinesterase and Butyrylcholinesterase | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Docking, dynamic simulation and quantum mechanics studies of pyrazinamide derivatives as novel inhibitors of Acetylcholinesterase and Butyrylcholinesterase

Author(s): Ismail Daoud 1,2* , Smail Bouarab 1,3 and Said Ghalem 2

Several cholinesterase ( Acetylcholinesterase and Butyrylcholinesterase) inhibitors are either being utilized for symptomatic treatment of Alzheimer’s disease or are in advanced clinical trials. A series of 12 known pyrazinamide derivatives that display inhibitory activity toward both acetylcholinesterase and butyrylcholinesteras e (ChEs) was considered for theoretical studies. These theoretic al approaches employed quantum mechanics and molecu lar docking data from both ChEs that were previously su bmitted to molecular dynamics (MD) simulations. Doc king studies revealed that the complex formed between Ch Es and the best pyrazinamide derivatives compounds reproduced the binding mode for theoretical calcula tion reported, where the ligand was coupled into th e choline-binding site and stabilized through the hyd rogen bonds interactions with Tyr121 or Tyr332 for AChE and BuChE, respectively, suggesting that these compound s could be an efficients inhibitors. The careful ana lysis of the investigation gave the compounds L 3 and L 4 as the most promising compounds based on the docki ng score energies and hydrogen bonds distances. The best possible int eractions of the lead compounds are simulated for s tability using molecular dynamics. The results of this inves tigation provide valuable information on the design of highly selective pyrazinamide derivatives.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry